Status:
UNKNOWN
A Study on the Endoscopic Treatments of Hemorrhoids
Lead Sponsor:
Fangyu Wang
Collaborating Sponsors:
The Second Affiliated Hospital of Nanjing University of Chinese Medicine
Conditions:
Hemorrhoids
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Hemorrhoids is one of the most common anorectal diseases, can occur at any age and gender. Hemorrhoids generally do not have very serious clinical manifestations, but often bring huge life pressure an...
Detailed Description
In this trial, investigators plan to conduct a multicenter, randomized controlled clinical trial. The leader of the sponsoring organization strictly implements oversight of the protocol. Investigators...
Eligibility Criteria
Inclusion
- Sign a written informed consent form.
- Age 18-80 years with clinical symptoms of hemorrhoids.
- Subjects able to follow the follow-up schedule, able to describe symptoms objectively and able to cooperate in completing the scale.
- non-breastfeeding pregnant women and those with no pregnancy planned during the trial
- not participating in various clinical trials in the 3 months prior to and during the trial
- Not taking long-term anticoagulant drugs (e.g., clopidogrel, aspirin, triptans, etc.) or have stopped taking them for 5-7 days.
Exclusion
- those with severe organ insufficiency of the heart, brain, lungs and kidneys
- those who cannot tolerate endoscopic treatment
- those with severe coagulation disorders
- men with a history of severe prostate enlargement
- with severe intestinal diseases: colon malignancy, ulcerative colitis, Crohn's disease, anal fistula, anal fissure, acute thrombosed internal hemorrhoids
- those who are allergic to sclerosing agents
- Those who, in the opinion of the investigator, cannot be enrolled for any reason.
Key Trial Info
Start Date :
May 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
285 Patients enrolled
Trial Details
Trial ID
NCT05268575
Start Date
May 30 2022
End Date
January 1 2025
Last Update
April 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jinling hospital
Nanjing, Jiangsu, China, 210002